Home › Vascular Malformations › Pennsylvania
Vascular Malformations clinical trials in Pennsylvania
4 studies for Vascular Malformations are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Nov 12, 2026 · NCT0678991324VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
2 Months – 30 Years · All sexes · Updated Oct 19, 2026 · NCT0754964624VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 2 to 30 · All sexes · Updated Oct 19, 2026 · NCT07543822Comprehensive HHT Outcomes Registry of the United States (CHORUS)
- University of Pennsylvania, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jul 17, 2026 · NCT06259292From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.